Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/15/2005US20050274447 post-processing of nanoscale powders of oxides, carbides, nitrides, borides, chalcogenides, metals, and alloys to improve their functional and processing characteristics thereby enabling their widespread use
12/15/2005DE102004026706A1 Orale Darreichungsform enthaltend probiotische Bakterien The oral dosage form containing probiotic bacteria
12/15/2005DE102004026679A1 Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone
12/15/2005DE102004026670A1 Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone
12/15/2005DE102004025503A1 Spray suitable for storage and administration of caffeine-containing substances
12/15/2005DE102004023288A1 Macrogol-Präparat Macrogol preparation
12/15/2005DE102004022927A1 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten 1,4 O-linked saccharose derivative instruments for stabilizing antibodies or antibody derivatives
12/15/2005DE102004022926A1 Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung Spray-dried powder containing at least one 1,4 O-linked saccharose derivative, and processes for their preparation
12/15/2005CA2580305A1 Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
12/15/2005CA2578806A1 Oral formulations of paricalcitol
12/15/2005CA2569514A1 Oral preparations and process for production thereof
12/15/2005CA2569513A1 Preformulation for liquid crystalline phase structure
12/15/2005CA2569067A1 Unagglomerated core/shell nanocomposite particles
12/15/2005CA2568801A1 Agent for removing circulatory dysfunction factor
12/15/2005CA2568641A1 Sustained release composition
12/15/2005CA2568616A1 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
12/15/2005CA2568598A1 Systems and methods for treating panic attacks
12/15/2005CA2568501A1 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
12/15/2005CA2568171A1 Oral administration form comprising probiotic bacteria
12/15/2005CA2568158A1 Treatment of amyotrophic lateral sclerosis
12/15/2005CA2567803A1 Injectable pharmaceutical suspension comprising posaconazole
12/15/2005CA2567688A1 Communication unit for a person's skin
12/15/2005CA2567310A1 Stabilized interferon liquid formulations
12/15/2005CA2567309A1 Method of stabilizing proteins
12/15/2005CA2565500A1 Vaccine compositions comprising virosomes and a saponin adjuvant
12/15/2005CA2563711A1 Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
12/15/2005CA2560984A1 Process for preparation of amorphous form of a drug
12/14/2005EP1604953A1 Noble metal-magnetic metal oxide composite particle and method for producing same
12/14/2005EP1604690A1 Polymeric compositions for sustained release of volatile materials
12/14/2005EP1604687A1 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
12/14/2005EP1604670A1 Supplemental food for recovery from hypoglycemic symptoms
12/14/2005EP1604661A1 Remedy for corneal ulcer
12/14/2005EP1604659A1 Tablet containing water-absorbing amino acid
12/14/2005EP1604657A1 Pharmaceutical formulation of a stable Formoterol-containing solution for use in inhalation therapy and method of preparing it
12/14/2005EP1604652A2 Topical anaesthetic preparation for pretreatment for upper gastrointestinal endoscopy
12/14/2005EP1604651A1 Transdermal patches and methods for delivering testosterone
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1604649A1 Composite material for use as protein carrier
12/14/2005EP1604647A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof
12/14/2005EP1604646A1 Viscous compositions containing carbon dioxide
12/14/2005EP1604645A1 Viscous compositions containing carbon dioxide
12/14/2005EP1603615A1 Improved dry powder inhaler system
12/14/2005EP1603607A2 Self-emulsifying compositions, methods of use and preparation
12/14/2005EP1603600A1 Polymer compositions with bioactive silver, copper or zinc compounds, medical articles, and processes
12/14/2005EP1603594A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof
12/14/2005EP1603589A1 Delivery system for drug and cell therapy
12/14/2005EP1603588A2 Stabilisation of growth hormones in solution
12/14/2005EP1603578A2 Cystitis treatment with high dose chondroitin sulfate
12/14/2005EP1603560A1 Topical immunotherapy and compositions for use therein
12/14/2005EP1603559A1 Pharmaceutical composition for intracellular acidification with cis-urocanic
12/14/2005EP1603550A1 Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid
12/14/2005EP1603547A1 Trospium containing compositions
12/14/2005EP1603544A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo 2.2.1 heptan-2-amine
12/14/2005EP1603540A2 A process for preparing sustained release tablets
12/14/2005EP1603539A1 Method of producing small microspheres of sugar, microspheres thus obtained and applications thereof
12/14/2005EP1603538A2 Impregnated powder improving bioavailability and/or solubility and method of production
12/14/2005EP1603537A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
12/14/2005EP1603536A2 Waxy matrix dosage forms
12/14/2005EP1603535A2 Aromatase inhibitor diagnosis and therapy
12/14/2005EP1603534A2 A method of treating a systemic disease
12/14/2005EP1603533A1 Opioid delivery system
12/14/2005EP1603532A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
12/14/2005EP1603531A2 Gel composition and method for treatment of vaginal infections
12/14/2005EP1603513A2 Treatment using dantrolene
12/14/2005EP1603499A2 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
12/14/2005EP1534283B1 Formulation of liposomal derivatives of phenylalanine
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005EP1471883B1 Method for producing water dispersible dry powders from poorly soluble compounds
12/14/2005EP1469938B1 Apparatus and process for preparing crystalline particles
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1439847A4 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
12/14/2005EP1357870A4 Bioadhesive cell foam film of sustained-release delivery
12/14/2005EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
12/14/2005EP1311296B1 Solution of an oxazolidinone antibiotic drug
12/14/2005EP1284771B1 Aerosol container for formulations of salmeterol xinafoate
12/14/2005EP1267880B1 Low dose entecavir formulation and use
12/14/2005EP1261421B1 Skincare agents
12/14/2005EP1248594B1 Multi-spike release formulation for drug delivery
12/14/2005EP1247526B1 Perfusion liquid preparations for ophthalmic operations
12/14/2005EP1217989B1 Vaccines for oral use which contain liposome-entrapped dna
12/14/2005EP1148870A4 Anti-plaque emulsions and products containing same
12/14/2005EP1107812B1 Gelatinous body protection article having a therapeutic additive
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP0831782B1 Methods and system for processing dispersible fine powders
12/14/2005CN1708514A Hydroxyalkyl starch derivatives
12/14/2005CN1708331A Formulations containing melatonin, ginkgo biloba, and biotin
12/14/2005CN1708314A Stabilized, solid-state polypeptide particles
12/14/2005CN1708307A Water-soluble meloxicam granules
12/14/2005CN1708301A Daily melatonin dosing units
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1708292A Fast dissolving films for oral administration of drugs
12/14/2005CN1708291A Transdermal therapeutic system provided with improved long-term carrying comfort
12/14/2005CN1708290A Dosage forms containing stabilized choline and method for preparing same
12/14/2005CN1708289A Edible PGA coating composition
12/14/2005CN1708288A Controlled-release compositions
12/14/2005CN1708287A Pharmaceutical and cosmetic formulations
12/14/2005CN1708283A Skin preparations for external use
12/14/2005CN1708281A Oral hygiene system and method of treatment
1 ... 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 ... 2991